BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

459 related articles for article (PubMed ID: 18383876)

  • 1. The ATM gene and ataxia telangiectasia.
    Mavrou A; Tsangaris GT; Roma E; Kolialexi A
    Anticancer Res; 2008; 28(1B):401-5. PubMed ID: 18383876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current and potential therapeutic strategies for the treatment of ataxia-telangiectasia.
    Lavin MF; Gueven N; Bottle S; Gatti RA
    Br Med Bull; 2007; 81-82():129-47. PubMed ID: 17586848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ataxia telangiectasia].
    Hosoi H; Sawada T
    Nihon Rinsho; 2000 Jul; 58(7):1505-10. PubMed ID: 10921332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ATM and breast cancer susceptibility.
    Ahmed M; Rahman N
    Oncogene; 2006 Sep; 25(43):5906-11. PubMed ID: 16998505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Ataxia-telangiectasia mutated gene and breast cancer: gene expression profiles and sequence variants.
    Hall J
    Cancer Lett; 2005 Sep; 227(2):105-14. PubMed ID: 16112413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role for ATM in DNA damage-induced phosphorylation of BRCA1.
    Gatei M; Scott SP; Filippovitch I; Soronika N; Lavin MF; Weber B; Khanna KK
    Cancer Res; 2000 Jun; 60(12):3299-304. PubMed ID: 10866324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ataxia-telangiectasia: from a rare disorder to a paradigm for cell signalling and cancer.
    Lavin MF
    Nat Rev Mol Cell Biol; 2008 Oct; 9(10):759-69. PubMed ID: 18813293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of ATM in breast cancer development.
    Prokopcova J; Kleibl Z; Banwell CM; Pohlreich P
    Breast Cancer Res Treat; 2007 Aug; 104(2):121-8. PubMed ID: 17061036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morbidity and mortality from ataxia-telangiectasia are associated with ATM genotype.
    Micol R; Ben Slama L; Suarez F; Le Mignot L; Beauté J; Mahlaoui N; Dubois d'Enghien C; Laugé A; Hall J; Couturier J; Vallée L; Delobel B; Rivier F; Nguyen K; Billette de Villemeur T; Stephan JL; Bordigoni P; Bertrand Y; Aladjidi N; Pedespan JM; Thomas C; Pellier I; Koenig M; Hermine O; Picard C; Moshous D; Neven B; Lanternier F; Blanche S; Tardieu M; Debré M; Fischer A; Stoppa-Lyonnet D;
    J Allergy Clin Immunol; 2011 Aug; 128(2):382-9.e1. PubMed ID: 21665257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the porcine ATM gene: towards the generation of a novel non-murine animal model for Ataxia-Telangiectasia.
    Rogatcheva MB; Fritz KL; Rund LA; Pollock CB; Beever JE; Counter CM; Schook LB
    Gene; 2007 Dec; 405(1-2):27-35. PubMed ID: 17933474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ataxia-telangiectasia: a review].
    Bott L; Thumerelle C; Cuvellier JC; Deschildre A; Vallée L; Sardet A
    Arch Pediatr; 2006 Mar; 13(3):293-8. PubMed ID: 16423518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presence of ATM protein and residual kinase activity correlates with the phenotype in ataxia-telangiectasia: a genotype-phenotype study.
    Verhagen MM; Last JI; Hogervorst FB; Smeets DF; Roeleveld N; Verheijen F; Catsman-Berrevoets CE; Wulffraat NM; Cobben JM; Hiel J; Brunt ER; Peeters EA; Gómez Garcia EB; van der Knaap MS; Lincke CR; Laan LA; Tijssen MA; van Rijn MA; Majoor-Krakauer D; Visser M; van 't Veer LJ; Kleijer WJ; van de Warrenburg BP; Warris A; de Groot IJ; de Groot R; Broeks A; Preijers F; Kremer BH; Weemaes CM; Taylor MA; van Deuren M; Willemsen MA
    Hum Mutat; 2012 Mar; 33(3):561-71. PubMed ID: 22213089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ATM mutations in cancer families.
    Vorechovský I; Luo L; Lindblom A; Negrini M; Webster AD; Croce CM; Hammarström L
    Cancer Res; 1996 Sep; 56(18):4130-3. PubMed ID: 8797579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of mutations in ATM to breast cancer development in the Czech population.
    Soukupova J; Dundr P; Kleibl Z; Pohlreich P
    Oncol Rep; 2008 Jun; 19(6):1505-10. PubMed ID: 18497957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atm heterozygosity does not increase tumor susceptibility to ionizing radiation alone or in a p53 heterozygous background.
    Mao JH; Wu D; DelRosario R; Castellanos A; Balmain A; Perez-Losada J
    Oncogene; 2008 Nov; 27(51):6596-600. PubMed ID: 18679420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cellular repair potential in families of ataxia-telangiectasia patients].
    Polubotko EA; Shatrova AN; Pleskach NM; Mikhel'son VM; Spivak IM
    Tsitologiia; 2009; 51(12):978-85. PubMed ID: 20141033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distal spinal muscular atrophy as a major feature in adult-onset ataxia telangiectasia.
    Hiel JA; van Engelen BG; Weemaes CM; Broeks A; Verrips A; ter Laak H; Vingerhoets HM; van den Heuvel LP; Lammens M; Gabreëls FJ; Last JI; Taylor AM
    Neurology; 2006 Jul; 67(2):346-9. PubMed ID: 16864838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular pathology of ataxia telangiectasia.
    Taylor AM; Byrd PJ
    J Clin Pathol; 2005 Oct; 58(10):1009-15. PubMed ID: 16189143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytoplasmic ATM protein kinase: an emerging therapeutic target for diabetes, cancer and neuronal degeneration.
    Yang DQ; Halaby MJ; Li Y; Hibma JC; Burn P
    Drug Discov Today; 2011 Apr; 16(7-8):332-8. PubMed ID: 21315178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atm-haploinsufficiency enhances susceptibility to carcinogen-induced mammary tumors.
    Lu S; Shen K; Wang Y; Santner SJ; Chen J; Brooks SC; Wang YA
    Carcinogenesis; 2006 Apr; 27(4):848-55. PubMed ID: 16400190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.